Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atogepant in episodic migraine (ELEVATE)
NCT04740827Phase 3Completed
- Sponsor
- Allergan
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of atogepant in episodic migraine, sponsored by Allergan. Started Mar 2021; status: completed.
02
Drugs
atogepant
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT04740827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04740827.